4 ms·
Good to see the blanket anti-drug hysteria of the last century being slowly dismantled. > Placebo controls pose another challenge because the drugs have such p
by kibwen 6y ago
Good to see the blanket anti-drug hysteria of the last century being slowly dismantled.
> Placebo controls pose another challenge because the drugs have such powerful effects.
This is fascinating and something I haven't considered before. Are there other example of major studies that have inherent difficulty forming a control group like this?
- anchpop 6y agoRelevant XKCD: https://xkcd.com/1462/ https://xkcd.com/1462/
- matthberg 6y agoEqually related yet much less relevant XKCD: https://xkcd.com/790/ https://xkcd.com/790/
- esperent 6y agoThat suggests to me that Randall Munroe has never taken psychedelics.
- heavenlyblue 6y agoSpiders and inability to scale things is one of the most common types of hallucination that is common to all paychedelics.
- _jcrossley 6y agoI found this fascinating as well. Sounds like a hard problem to solve - I'm skeptical and surprised that "niacin, which elicits a physical sensation — usually a flushing response in the skin" was effective as a placebo
- LocalH 6y agoI can't imagine it would be an effective placebo with any person who has ever had prior psychedelic experience, once enough time has passed. Perhaps in the pre-peak period where it's already kind of fuzzy when the effects start to kick in, but not anywhere near the peak
- PragmaticPulp 6y agoIt's a challenge, but it's hardly a show-stopper. Studies can use active placebo to make patients feel something dramatic. Some times they use drugs like Xanax which induce noticeable sedated states, for example. Double-blind, placebo controlled studies are the gold standard, but not the only option. It's common to compare against another known-good treatment option. For example, you might structure the study such that one group receives 16 weeks of standard therapy, while the second group receives 16 weeks of the same therapy, but with the addition of of psychedelic sessions on weeks 8 and 12. If the psychedelics have a positive impact, you would expect greater divergence between the two groups after the psychedelic sessions. Sadly, current studies don't actually point to a significant benefit from psychedelics when compared to standard therapy sessions. In the last study I viewed the used therapy with a few psychedelic sessions, it appeared that the vast majority of improvement came strictly from the therapy, before the psychedelics were even introduced. In fact, from the graph of patient improvement I couldn't tell if the psychedelics had any effect at all. The study basically showed that psychedelics didn't make therapy worse than normal, but that's about it.
- jdashg 6y agoMethyline Blue is tricky to test because it really does turn things super blue. Interestingly, this is sometimes used as a powerful placebo in other studies, since it sure does convince people they aren't taking a sugar pill! https://en.m.wikipedia.org/wiki/Methylene_blue#Placebo https://en.m.wikipedia.org/wiki/Methylene_blue#Placebo
- vwoolf 6y agoHaving had severe diagnosed depression and having also taken MDMA at parties and with friends, I see why it is, if not a miracle drug, then at least a powerful and potent tool. I credit it with much of my quality of life today.